Why START? Reflections that led to the conduct of this large long-term strategic HIV trial

Research output: Contribution to journalEditorialResearchpeer-review

  • Lundgren, Jens
  • Abdel Babiker
  • Fred Gordin
  • Sean Emery
  • Gerd Fätkenheuer
  • Jean-Michel Molina
  • Robin Wood
  • James D Neaton
  • INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group
Original languageEnglish
JournalHIV Medicine
Volume16
Issue numberSuppl 1
Pages (from-to)1-9
Number of pages9
ISSN1464-2662
DOIs
Publication statusPublished - Apr 2015

    Research areas

  • Adult, Anti-Retroviral Agents, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, Cohort Studies, Female, HIV Infections, Humans, Male, Randomized Controlled Trials as Topic, Time Factors, Treatment Outcome

ID: 161689972